Success Metrics

Completion Rate

0%(0/1)

Active Trials

0(0%)

Terminated

1(33%)

Phase Distribution

Ph phase_2

33%

Ph not_applicable

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

Phase 2Efficacy & side effects

1(50.0%)

N/ANon-phased studies

1(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Terminated(1)

Other(1)

Detailed Status

unknown1

Enrolling by invitation1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

0.0%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (50.0%)

N/A1 (50.0%)

Trials by Status

unknown133%

enrolling_by_invitation133%

terminated133%

Recent Activity

0 active trials

Showing 3 of 3

terminatednot_applicable

SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases

NCT03694015

enrolling_by_invitation

A Single-Arm Study on the Efficacy of Sequential Chemoradiotherapy Followed by Surgery in Adult Nasal and Paranasal Sinus Rhabdomyosarcoma

NCT07449949

unknownphase_2

Nimotuzumab Combined With VMAT in Elderly Patients With Nasopharyngeal Carcinoma

NCT03915132

Clinical Trials (3)

Showing 3 of 3 trials

NCT03694015Not Applicable

SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases

Terminated

NCT07449949

A Single-Arm Study on the Efficacy of Sequential Chemoradiotherapy Followed by Surgery in Adult Nasal and Paranasal Sinus Rhabdomyosarcoma

Enrolling By Invitation

NCT03915132Phase 2

Nimotuzumab Combined With VMAT in Elderly Patients With Nasopharyngeal Carcinoma

Unknown

All 3 trials loaded

Drug Details

Intervention Type: RADIATION
Total Trials: 3